NorthWest Biotherapeutics Inc (NWBO)

[The Danish Dude]

ATL-DC is DCVax-L ... in short for shorters and fudders.

The "game over" manual to be linked to, when being exposed to FUD bullshit.

1) Linda Liau told Al Musella during the Q&A of a webinar december 2022.



The Q&A also mentioned DCVax-L in combo trial with POLY-ICL, using the phrase "TLR agonist"



Do you remember the upcoming Nature article regarding this combo trial?

https://www.researchsquare.com/article/rs-3287211/v1




See ... three UCLA doctors are in that trial:

Robert Prins, Timothy Cloughesy and Linda Liau

But NWBO has nothing to do with that trial, right ex, HyGro and LC?



Mr. Cloughesy ALSO said, ATL-DC is DCVax-L during a webinar





Maybe because he is ALSO the principal investigator in the SPORE 1 UCLA combo trial with DCvax-L and Keytruda?



https://classic.clinicaltrials.gov/ct2/show/NCT04201873

Maybe because he's also a part of the team above, who is publishing the Nature article about the combo trial with DCvax-L and Poly-iclc?

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568250/

Take a look at this video by Dr. Cloughesy at UCLA, then go to the 1:30 mark to see that DCVax (ATL-DC) is the dendritic cell vaccine that UCLA uses in combination with a PD-1 inhibitor (Pembrolizumab / Keytruda).

https://vimeo.com/492232511



Then go to the 31:10 mark to see what vaccines are used by UCLA to get the immune cell to the tumor to fight the tumor. The only dendritic cell listed is DCVax.



UCLA is even directly mentioning their use of DCvax-L at their own website

https://www.uclahealth.org/cancer/cancer-services/brain-tumor/about-us



https://www.uclahealth.org/cancer/cancer-services/brain-tumor/treatments/biologics



https://www.uclahealth.org/cancer/cancer-services/brain-tumor/research-clinical-trials



https://www.uclahealth.org/news/fda-approval-brain-cancer-alzheimers



Oups ... you were saying?



GAME OVER MAN!